March 3, 2026 · Form 4 insider transaction
Chiprin Jeff bought 1,150 shares of IRADIMED CORP at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.; The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 7, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.